206 related articles for article (PubMed ID: 28388538)
1. Nomograms for predicting progression and efficacy of post-operation radiotherapy in IIIA-pN2 non-small cell lung cancer patients.
Zhang B; Yuan Z; Zhao L; Pang Q; Wang P
Oncotarget; 2017 Jun; 8(23):37208-37216. PubMed ID: 28388538
[TBL] [Abstract][Full Text] [Related]
2. The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.
Feng W; Zhang Q; Fu XL; Cai XW; Zhu ZF; Yang HJ; Xiang JQ; Zhang YW; Chen HQ
BMC Cancer; 2015 May; 15():348. PubMed ID: 25934006
[TBL] [Abstract][Full Text] [Related]
3. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms.
Kang J; Ning MS; Feng H; Li H; Bahig H; Brooks ED; Welsh JW; Ye R; Miao H; Chang JY
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):90-99. PubMed ID: 31586665
[TBL] [Abstract][Full Text] [Related]
4. Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer.
Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Komaki R; Hu Y; Hahn SM; Liao Z
Cancer Med; 2018 Jun; 7(6):2247-2255. PubMed ID: 29745043
[TBL] [Abstract][Full Text] [Related]
5. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
6. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.
Wei S; Xie M; Tian J; Song X; Wu B; Liu L
Radiat Oncol; 2017 Jun; 12(1):96. PubMed ID: 28610591
[TBL] [Abstract][Full Text] [Related]
7. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer Data Base.
Robinson CG; Patel AP; Bradley JD; DeWees T; Waqar SN; Morgensztern D; Baggstrom MQ; Govindan R; Bell JM; Guthrie TJ; Colditz GA; Crabtree TD; Kreisel D; Krupnick AS; Patterson GA; Meyers BF; Puri V
J Clin Oncol; 2015 Mar; 33(8):870-6. PubMed ID: 25667283
[TBL] [Abstract][Full Text] [Related]
8. Patient prognostic scores and association with survival improvement offered by postoperative radiotherapy for resected IIIA/N2 non-small cell lung cancer: A population-based study.
Xu L; Xie HN; Chen XK; Bi N; Qin JJ; Li Y
Thorac Cancer; 2021 Mar; 12(6):760-767. PubMed ID: 33481353
[TBL] [Abstract][Full Text] [Related]
9. Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG; Owonikoko TK; Pillai RN; Khuri FR; Curran WJ; Higgins KA
J Thorac Oncol; 2015 Mar; 10(3):462-71. PubMed ID: 25384064
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032).
Kent MS; Mandrekar SJ; Landreneau R; Nichols F; Foster NR; DiPetrillo TA; Meyers B; Heron DE; Jones DR; Tan AD; Starnes S; Putnam JB; Fernando HC
Ann Thorac Surg; 2016 Jul; 102(1):239-46. PubMed ID: 27101729
[TBL] [Abstract][Full Text] [Related]
11. The high-risk features and effect of postoperative radiotherapy on survival for patients with surgically treated stage IIIA-N2 non-small cell lung cancer.
Zhu M; Li S; Yuan L; Liu S; Li J; Zhang D; Chen J; Jiang J; Xu Z
World J Surg Oncol; 2023 Aug; 21(1):238. PubMed ID: 37537652
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
13. Establishment and validation of a predictive nomogram model for non-small cell lung cancer patients with chronic hepatitis B viral infection.
Chen S; Lai Y; He Z; Li J; He X; Shen R; Ding Q; Chen H; Peng S; Liu W
J Transl Med; 2018 May; 16(1):116. PubMed ID: 29728103
[TBL] [Abstract][Full Text] [Related]
14. Nomograms for predicting disease progression in patients of Stage I non-small cell lung cancer treated with stereotactic body radiotherapy.
Ye L; Shi S; Zeng Z; Huang Y; Hu Y; He J
Jpn J Clin Oncol; 2018 Feb; 48(2):160-166. PubMed ID: 29253245
[TBL] [Abstract][Full Text] [Related]
15. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
Rieber J; Deeg A; Ullrich E; Foerster R; Bischof M; Warth A; Schnabel PA; Muley T; Kappes J; Heussel CP; Welzel T; Thomas M; Steins M; Dienemann H; Debus J; Hoffmann H; Rieken S
Lung Cancer; 2016 Jan; 91():41-7. PubMed ID: 26711933
[TBL] [Abstract][Full Text] [Related]
16. Postoperative intensity-modulated radiation therapy reduces local recurrence and improves overall survival in III-N2 non-small-cell lung cancer: A single-center, retrospective study.
Wei W; Zhou J; Zhang Q; Liao DH; Liu QD; Zhong BL; Liang ZB; Zhang YC; Jiang R; Liu GY; Xu CY; Li Zhou H; Zhu SY; Yang N; Jiang W; Liu ZG
Cancer Med; 2020 Apr; 9(8):2820-2832. PubMed ID: 32100444
[TBL] [Abstract][Full Text] [Related]
17. A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab.
Botticelli A; Salati M; Di Pietro FR; Strigari L; Cerbelli B; Zizzari IG; Giusti R; Mazzotta M; Mazzuca F; Roberto M; Vici P; Pizzuti L; Nuti M; Marchetti P
J Transl Med; 2019 Mar; 17(1):99. PubMed ID: 30917841
[TBL] [Abstract][Full Text] [Related]
18. Post-operative radiotherapy in N2 non-small cell lung cancer: a retrospective analysis of 175 patients.
Scotti V; Meattini I; Saieva C; Agresti B; de Luca Cardillo C; Bastiani P; Livi L; Mangoni M; Di Cataldo V; Marrazzo L; Rampini A; Cipressi S; Bruni A; Santini P; Biti G
Radiother Oncol; 2010 Jul; 96(1):84-8. PubMed ID: 20541823
[TBL] [Abstract][Full Text] [Related]
19. Modern post-operative radiotherapy for stage III non-small cell lung cancer may improve local control and survival: a meta-analysis.
Billiet C; Decaluwé H; Peeters S; Vansteenkiste J; Dooms C; Haustermans K; De Leyn P; De Ruysscher D
Radiother Oncol; 2014 Jan; 110(1):3-8. PubMed ID: 24100149
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved.
Matsuguma H; Nakahara R; Ishikawa Y; Suzuki H; Inoue K; Katano S; Yokoi K
Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):573-7. PubMed ID: 18413349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
